Malayan, Lorna M.

HRN: 28-52-83  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/11/2026
CEFTAZIDIME 1GM (VIAL)
02/11/2026
02/18/2026
IV
2g
Q24
HAP
Checking Initial Appropriateness 
02/11/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
02/11/2026
02/18/2026
IV
750mg
LD
HAP
Checking Initial Appropriateness 
02/11/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
02/11/2026
02/18/2026
IV
500mg
Q48
HAP
Checking Initial Appropriateness 
02/13/2026
MUPIROCIN 2%, 15G (TUBE)
02/13/2026
02/19/2026
TOPICAL
Apply Thinly
BID
Sacral Ulcer
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: